Pre-existence of invasive cells in breast ductal carcinoma in situ.
Virginia Espina(George Mason University), L A Liotta, Kevin Tran(The University of Melbourne), Claudius Mueller(Mayo Clinic), Kirsten H. Edmiston(Inova Health System), Lucio Pastore(Ceinge Biotecnologie Avanzate (Italy)), Brian D. Mariani(Genetics and IVF Institute), Rosa I. Gallagher(George Mason University), Shelia Banks
Cited by 0
Related Papers
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
|Cancer Cell|2022|335
A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process
|Molecular & Cellular Proteomics|2008|205
Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival
|PLoS ONE|2010|149
An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models
|Breast Cancer Research|2013|146
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
|Clinical Cancer Research|2012|124